Bloodstream infections
2 trials- 2020CAMERA2MRSA bacteraemiaIn 352 patients with MRSA bacteraemia, standard therapy plus an anti-staphylococcal β-lactam did not improve a composite of mortality, persistent bacteraemia and relapse versus standard therapy alone — and acute kidney injury increased.
- 2018MERINOESBL bacteraemiaIn 391 patients with ceftriaxone-non-susceptible E. coli or K. pneumoniae bacteraemia, piperacillin-tazobactam increased 30-day mortality compared with meropenem.